Nummer | Titel | ECTS | Umfang | Dozierende |
---|
511-0000-00L | Drug Discovery and Development | 2 KP | 1G + 2S | J. Hall,
U. Thibaut,
K.‑H. Altmann,
M. Arand,
J. Scheuermann,
R. Schibli,
H. U. Zeilhofer |
535-0001-00L | Einführung in die Pharmazeutischen Wissenschaften I | 2 KP | 2V | J. Hall,
S.‑D. Krämer,
J.‑C. Leroux,
B. Pfeiffer,
U. Quitterer,
J. Scheuermann,
R. Schibli,
Y. Yamauchi,
H. U. Zeilhofer |
535-0011-00L | Drug Seminar | 5 KP | 9S | J.‑C. Leroux,
A. Burden,
K. Eyer,
C. Halin Winter,
J. Hall,
S.‑D. Krämer,
C. Müller,
V. I. Otto,
U. Quitterer,
J. Scheuermann,
R. Schibli,
K. Silina,
C. Steuer |
535-0210-00L | Radiopharmazeutische Chemie | 2 KP | 2V | R. Schibli,
L. Mu |
535-0900-00L | Seminars on Drug Discovery and Development | 1 KP | 1K | R. Schibli,
K. Eyer,
C. Halin Winter,
J. Hall,
J.‑C. Leroux,
U. Quitterer,
G. Schneider,
H. U. Zeilhofer |
535-0901-00L | From A to Z in Drug Discovery and Development | 1 KP | 2S | J. Hall,
K.‑H. Altmann,
M. Arand,
J. Scheuermann,
R. Schibli,
H. U. Zeilhofer |
541-0002-00L | Module 2: Pharma Project Management and Health Communication Findet dieses Semester nicht statt. Only for CAS in Pharmaceuticals.
The enrolment is done by the CAS in Pharmaceuticals study administration. | 2.5 KP | 3G | R. Schibli |
541-0007-00L | Module 7: Clinical Development Only for CAS in Pharmaceuticals.
The enrolment is done by the CAS in Pharmaceuticals study administration. | 2.5 KP | 3G | R. Furegati Hafner,
R. Schibli |
541-1000-00L | Essay Nur für CAS in Pharmaceuticals.
Einschreibung nur über das Sekretariat des CAS in Pharmaceuticals. | 1 KP | 2D | R. Furegati Hafner,
R. Schibli |
542-0001-00L | Module I: Pharmacy and Legislation Only for CAS in Radiopharmazeutischer Chemie, Radiopharmacy.
The enrolment is done by the CAS study administration. | 4 KP | 6G | R. Schibli,
R. Furegati Hafner |
542-0003-00L | Module III: Radiopharmacology and Clinical Radiopharmacy Findet dieses Semester nicht statt. Only for CAS in Radiopharmazeutischer Chemie, Radiopharmacy.
The enrolment is done by the CAS study administration. | 4 KP | 6G | R. Schibli |